Global Sexually Transmitted Diseases Diagnostics Market 2026 by Company, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Sexually Transmitted Diseases Diagnostics market size was valued at US$ 4834 million in 2025 and is forecast to a readjusted size of US$ 7497 million by 2032 with a CAGR of 6.5% during review period.
Sexually Transmitted Diseases (STDs) Diagnostics refer to the medical tests and procedures used to detect infections transmitted through sexual contact. These diagnostics encompass a variety of methods, including laboratory tests such as blood tests, urine tests, swabs, and culture tests, as well as rapid diagnostic tests and molecular techniques like polymerase chain reaction (PCR). The purpose of these diagnostics is to identify the presence of pathogens like bacteria, viruses, or parasites responsible for STDs, enabling timely and accurate diagnosis, which is essential for effective treatment and prevention of further transmission.
This report is a detailed and comprehensive analysis for global Sexually Transmitted Diseases Diagnostics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Sexually Transmitted Diseases (STDs) Diagnostics refer to the medical tests and procedures used to detect infections transmitted through sexual contact. These diagnostics encompass a variety of methods, including laboratory tests such as blood tests, urine tests, swabs, and culture tests, as well as rapid diagnostic tests and molecular techniques like polymerase chain reaction (PCR). The purpose of these diagnostics is to identify the presence of pathogens like bacteria, viruses, or parasites responsible for STDs, enabling timely and accurate diagnosis, which is essential for effective treatment and prevention of further transmission.
This report is a detailed and comprehensive analysis for global Sexually Transmitted Diseases Diagnostics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
- Global Sexually Transmitted Diseases Diagnostics market size and forecasts, in consumption value ($ Million), 2021-2032
- Global Sexually Transmitted Diseases Diagnostics market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
- Global Sexually Transmitted Diseases Diagnostics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
- Global Sexually Transmitted Diseases Diagnostics market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Sexually Transmitted Diseases Diagnostics
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Sexually Transmitted Diseases Diagnostics market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.Market segment by Type
- Cultural and Isolated Organisms
- Molecular Test
- Immunology Assay
- Other
Market segment by Application
- Gonorrhea
- Syphilis
- Chlamydia
- Herpes Simplex Virus
- Human Papillomavirus
- Others
Market segment by players, this report covers
- Abbott
- Thermo Fisher Scientific
- CERTEST BIOTEC
- OPERON
- Roche
- Bio-Rad laboratories
- Qaigen
- Diasorin SPA
- MedMira
- Hologic
- Cepheid
- BioMeriuex
Market segment by regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
- South America (Brazil, Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
- Chapter 1, to describe Sexually Transmitted Diseases Diagnostics product scope, market overview, market estimation caveats and base year.
- Chapter 2, to profile the top players of Sexually Transmitted Diseases Diagnostics, with revenue, gross margin, and global market share of Sexually Transmitted Diseases Diagnostics from 2021 to 2026.
- Chapter 3, the Sexually Transmitted Diseases Diagnostics competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
- Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
- Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Sexually Transmitted Diseases Diagnostics market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
- Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
- Chapter 12, the key raw materials and key suppliers, and industry chain of Sexually Transmitted Diseases Diagnostics.
- Chapter 13, to describe Sexually Transmitted Diseases Diagnostics research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Sexually Transmitted Diseases Diagnostics by Type
1.3.1 Overview: Global Sexually Transmitted Diseases Diagnostics Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Sexually Transmitted Diseases Diagnostics Consumption Value Market Share by Type in 2025
1.3.3 Cultural and Isolated Organisms
1.3.4 Molecular Test
1.3.5 Immunology Assay
1.3.6 Other
1.4 Global Sexually Transmitted Diseases Diagnostics Market by Application
1.4.1 Overview: Global Sexually Transmitted Diseases Diagnostics Market Size by Application: 2021 Versus 2025 Versus 2032
1.4.2 Gonorrhea
1.4.3 Syphilis
1.4.4 Chlamydia
1.4.5 Herpes Simplex Virus
1.4.6 Human Papillomavirus
1.4.7 Others
1.5 Global Sexually Transmitted Diseases Diagnostics Market Size & Forecast
1.6 Global Sexually Transmitted Diseases Diagnostics Market Size and Forecast by Region
1.6.1 Global Sexually Transmitted Diseases Diagnostics Market Size by Region: 2021 VS 2025 VS 2032
1.6.2 Global Sexually Transmitted Diseases Diagnostics Market Size by Region, (2021-2032)
1.6.3 North America Sexually Transmitted Diseases Diagnostics Market Size and Prospect (2021-2032)
1.6.4 Europe Sexually Transmitted Diseases Diagnostics Market Size and Prospect (2021-2032)
1.6.5 Asia-Pacific Sexually Transmitted Diseases Diagnostics Market Size and Prospect (2021-2032)
1.6.6 South America Sexually Transmitted Diseases Diagnostics Market Size and Prospect (2021-2032)
1.6.7 Middle East & Africa Sexually Transmitted Diseases Diagnostics Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott Sexually Transmitted Diseases Diagnostics Product and Solutions
2.1.4 Abbott Sexually Transmitted Diseases Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Abbott Recent Developments and Future Plans
2.2 Thermo Fisher Scientific
2.2.1 Thermo Fisher Scientific Details
2.2.2 Thermo Fisher Scientific Major Business
2.2.3 Thermo Fisher Scientific Sexually Transmitted Diseases Diagnostics Product and Solutions
2.2.4 Thermo Fisher Scientific Sexually Transmitted Diseases Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.3 CERTEST BIOTEC
2.3.1 CERTEST BIOTEC Details
2.3.2 CERTEST BIOTEC Major Business
2.3.3 CERTEST BIOTEC Sexually Transmitted Diseases Diagnostics Product and Solutions
2.3.4 CERTEST BIOTEC Sexually Transmitted Diseases Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 CERTEST BIOTEC Recent Developments and Future Plans
2.4 OPERON
2.4.1 OPERON Details
2.4.2 OPERON Major Business
2.4.3 OPERON Sexually Transmitted Diseases Diagnostics Product and Solutions
2.4.4 OPERON Sexually Transmitted Diseases Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 OPERON Recent Developments and Future Plans
2.5 Roche
2.5.1 Roche Details
2.5.2 Roche Major Business
2.5.3 Roche Sexually Transmitted Diseases Diagnostics Product and Solutions
2.5.4 Roche Sexually Transmitted Diseases Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Roche Recent Developments and Future Plans
2.6 Bio-Rad laboratories
2.6.1 Bio-Rad laboratories Details
2.6.2 Bio-Rad laboratories Major Business
2.6.3 Bio-Rad laboratories Sexually Transmitted Diseases Diagnostics Product and Solutions
2.6.4 Bio-Rad laboratories Sexually Transmitted Diseases Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Bio-Rad laboratories Recent Developments and Future Plans
2.7 Qaigen
2.7.1 Qaigen Details
2.7.2 Qaigen Major Business
2.7.3 Qaigen Sexually Transmitted Diseases Diagnostics Product and Solutions
2.7.4 Qaigen Sexually Transmitted Diseases Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Qaigen Recent Developments and Future Plans
2.8 Diasorin SPA
2.8.1 Diasorin SPA Details
2.8.2 Diasorin SPA Major Business
2.8.3 Diasorin SPA Sexually Transmitted Diseases Diagnostics Product and Solutions
2.8.4 Diasorin SPA Sexually Transmitted Diseases Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Diasorin SPA Recent Developments and Future Plans
2.9 MedMira
2.9.1 MedMira Details
2.9.2 MedMira Major Business
2.9.3 MedMira Sexually Transmitted Diseases Diagnostics Product and Solutions
2.9.4 MedMira Sexually Transmitted Diseases Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 MedMira Recent Developments and Future Plans
2.10 Hologic
2.10.1 Hologic Details
2.10.2 Hologic Major Business
2.10.3 Hologic Sexually Transmitted Diseases Diagnostics Product and Solutions
2.10.4 Hologic Sexually Transmitted Diseases Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Hologic Recent Developments and Future Plans
2.11 Cepheid
2.11.1 Cepheid Details
2.11.2 Cepheid Major Business
2.11.3 Cepheid Sexually Transmitted Diseases Diagnostics Product and Solutions
2.11.4 Cepheid Sexually Transmitted Diseases Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Cepheid Recent Developments and Future Plans
2.12 BioMeriuex
2.12.1 BioMeriuex Details
2.12.2 BioMeriuex Major Business
2.12.3 BioMeriuex Sexually Transmitted Diseases Diagnostics Product and Solutions
2.12.4 BioMeriuex Sexually Transmitted Diseases Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 BioMeriuex Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Sexually Transmitted Diseases Diagnostics Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Sexually Transmitted Diseases Diagnostics by Company Revenue
3.2.2 Top 3 Sexually Transmitted Diseases Diagnostics Players Market Share in 2025
3.2.3 Top 6 Sexually Transmitted Diseases Diagnostics Players Market Share in 2025
3.3 Sexually Transmitted Diseases Diagnostics Market: Overall Company Footprint Analysis
3.3.1 Sexually Transmitted Diseases Diagnostics Market: Region Footprint
3.3.2 Sexually Transmitted Diseases Diagnostics Market: Company Product Type Footprint
3.3.3 Sexually Transmitted Diseases Diagnostics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Sexually Transmitted Diseases Diagnostics Consumption Value and Market Share by Type (2021-2026)
4.2 Global Sexually Transmitted Diseases Diagnostics Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Sexually Transmitted Diseases Diagnostics Consumption Value Market Share by Application (2021-2026)
5.2 Global Sexually Transmitted Diseases Diagnostics Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Sexually Transmitted Diseases Diagnostics Consumption Value by Type (2021-2032)
6.2 North America Sexually Transmitted Diseases Diagnostics Market Size by Application (2021-2032)
6.3 North America Sexually Transmitted Diseases Diagnostics Market Size by Country
6.3.1 North America Sexually Transmitted Diseases Diagnostics Consumption Value by Country (2021-2032)
6.3.2 United States Sexually Transmitted Diseases Diagnostics Market Size and Forecast (2021-2032)
6.3.3 Canada Sexually Transmitted Diseases Diagnostics Market Size and Forecast (2021-2032)
6.3.4 Mexico Sexually Transmitted Diseases Diagnostics Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Sexually Transmitted Diseases Diagnostics Consumption Value by Type (2021-2032)
7.2 Europe Sexually Transmitted Diseases Diagnostics Consumption Value by Application (2021-2032)
7.3 Europe Sexually Transmitted Diseases Diagnostics Market Size by Country
7.3.1 Europe Sexually Transmitted Diseases Diagnostics Consumption Value by Country (2021-2032)
7.3.2 Germany Sexually Transmitted Diseases Diagnostics Market Size and Forecast (2021-2032)
7.3.3 France Sexually Transmitted Diseases Diagnostics Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Sexually Transmitted Diseases Diagnostics Market Size and Forecast (2021-2032)
7.3.5 Russia Sexually Transmitted Diseases Diagnostics Market Size and Forecast (2021-2032)
7.3.6 Italy Sexually Transmitted Diseases Diagnostics Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Sexually Transmitted Diseases Diagnostics Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Sexually Transmitted Diseases Diagnostics Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Sexually Transmitted Diseases Diagnostics Market Size by Region
8.3.1 Asia-Pacific Sexually Transmitted Diseases Diagnostics Consumption Value by Region (2021-2032)
8.3.2 China Sexually Transmitted Diseases Diagnostics Market Size and Forecast (2021-2032)
8.3.3 Japan Sexually Transmitted Diseases Diagnostics Market Size and Forecast (2021-2032)
8.3.4 South Korea Sexually Transmitted Diseases Diagnostics Market Size and Forecast (2021-2032)
8.3.5 India Sexually Transmitted Diseases Diagnostics Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Sexually Transmitted Diseases Diagnostics Market Size and Forecast (2021-2032)
8.3.7 Australia Sexually Transmitted Diseases Diagnostics Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Sexually Transmitted Diseases Diagnostics Consumption Value by Type (2021-2032)
9.2 South America Sexually Transmitted Diseases Diagnostics Consumption Value by Application (2021-2032)
9.3 South America Sexually Transmitted Diseases Diagnostics Market Size by Country
9.3.1 South America Sexually Transmitted Diseases Diagnostics Consumption Value by Country (2021-2032)
9.3.2 Brazil Sexually Transmitted Diseases Diagnostics Market Size and Forecast (2021-2032)
9.3.3 Argentina Sexually Transmitted Diseases Diagnostics Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Sexually Transmitted Diseases Diagnostics Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Sexually Transmitted Diseases Diagnostics Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Sexually Transmitted Diseases Diagnostics Market Size by Country
10.3.1 Middle East & Africa Sexually Transmitted Diseases Diagnostics Consumption Value by Country (2021-2032)
10.3.2 Turkey Sexually Transmitted Diseases Diagnostics Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Sexually Transmitted Diseases Diagnostics Market Size and Forecast (2021-2032)
10.3.4 UAE Sexually Transmitted Diseases Diagnostics Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Sexually Transmitted Diseases Diagnostics Market Drivers
11.2 Sexually Transmitted Diseases Diagnostics Market Restraints
11.3 Sexually Transmitted Diseases Diagnostics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Sexually Transmitted Diseases Diagnostics Industry Chain
12.2 Sexually Transmitted Diseases Diagnostics Upstream Analysis
12.3 Sexually Transmitted Diseases Diagnostics Midstream Analysis
12.4 Sexually Transmitted Diseases Diagnostics Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Sexually Transmitted Diseases Diagnostics by Type
1.3.1 Overview: Global Sexually Transmitted Diseases Diagnostics Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Sexually Transmitted Diseases Diagnostics Consumption Value Market Share by Type in 2025
1.3.3 Cultural and Isolated Organisms
1.3.4 Molecular Test
1.3.5 Immunology Assay
1.3.6 Other
1.4 Global Sexually Transmitted Diseases Diagnostics Market by Application
1.4.1 Overview: Global Sexually Transmitted Diseases Diagnostics Market Size by Application: 2021 Versus 2025 Versus 2032
1.4.2 Gonorrhea
1.4.3 Syphilis
1.4.4 Chlamydia
1.4.5 Herpes Simplex Virus
1.4.6 Human Papillomavirus
1.4.7 Others
1.5 Global Sexually Transmitted Diseases Diagnostics Market Size & Forecast
1.6 Global Sexually Transmitted Diseases Diagnostics Market Size and Forecast by Region
1.6.1 Global Sexually Transmitted Diseases Diagnostics Market Size by Region: 2021 VS 2025 VS 2032
1.6.2 Global Sexually Transmitted Diseases Diagnostics Market Size by Region, (2021-2032)
1.6.3 North America Sexually Transmitted Diseases Diagnostics Market Size and Prospect (2021-2032)
1.6.4 Europe Sexually Transmitted Diseases Diagnostics Market Size and Prospect (2021-2032)
1.6.5 Asia-Pacific Sexually Transmitted Diseases Diagnostics Market Size and Prospect (2021-2032)
1.6.6 South America Sexually Transmitted Diseases Diagnostics Market Size and Prospect (2021-2032)
1.6.7 Middle East & Africa Sexually Transmitted Diseases Diagnostics Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott Sexually Transmitted Diseases Diagnostics Product and Solutions
2.1.4 Abbott Sexually Transmitted Diseases Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Abbott Recent Developments and Future Plans
2.2 Thermo Fisher Scientific
2.2.1 Thermo Fisher Scientific Details
2.2.2 Thermo Fisher Scientific Major Business
2.2.3 Thermo Fisher Scientific Sexually Transmitted Diseases Diagnostics Product and Solutions
2.2.4 Thermo Fisher Scientific Sexually Transmitted Diseases Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.3 CERTEST BIOTEC
2.3.1 CERTEST BIOTEC Details
2.3.2 CERTEST BIOTEC Major Business
2.3.3 CERTEST BIOTEC Sexually Transmitted Diseases Diagnostics Product and Solutions
2.3.4 CERTEST BIOTEC Sexually Transmitted Diseases Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 CERTEST BIOTEC Recent Developments and Future Plans
2.4 OPERON
2.4.1 OPERON Details
2.4.2 OPERON Major Business
2.4.3 OPERON Sexually Transmitted Diseases Diagnostics Product and Solutions
2.4.4 OPERON Sexually Transmitted Diseases Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 OPERON Recent Developments and Future Plans
2.5 Roche
2.5.1 Roche Details
2.5.2 Roche Major Business
2.5.3 Roche Sexually Transmitted Diseases Diagnostics Product and Solutions
2.5.4 Roche Sexually Transmitted Diseases Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Roche Recent Developments and Future Plans
2.6 Bio-Rad laboratories
2.6.1 Bio-Rad laboratories Details
2.6.2 Bio-Rad laboratories Major Business
2.6.3 Bio-Rad laboratories Sexually Transmitted Diseases Diagnostics Product and Solutions
2.6.4 Bio-Rad laboratories Sexually Transmitted Diseases Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Bio-Rad laboratories Recent Developments and Future Plans
2.7 Qaigen
2.7.1 Qaigen Details
2.7.2 Qaigen Major Business
2.7.3 Qaigen Sexually Transmitted Diseases Diagnostics Product and Solutions
2.7.4 Qaigen Sexually Transmitted Diseases Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Qaigen Recent Developments and Future Plans
2.8 Diasorin SPA
2.8.1 Diasorin SPA Details
2.8.2 Diasorin SPA Major Business
2.8.3 Diasorin SPA Sexually Transmitted Diseases Diagnostics Product and Solutions
2.8.4 Diasorin SPA Sexually Transmitted Diseases Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Diasorin SPA Recent Developments and Future Plans
2.9 MedMira
2.9.1 MedMira Details
2.9.2 MedMira Major Business
2.9.3 MedMira Sexually Transmitted Diseases Diagnostics Product and Solutions
2.9.4 MedMira Sexually Transmitted Diseases Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 MedMira Recent Developments and Future Plans
2.10 Hologic
2.10.1 Hologic Details
2.10.2 Hologic Major Business
2.10.3 Hologic Sexually Transmitted Diseases Diagnostics Product and Solutions
2.10.4 Hologic Sexually Transmitted Diseases Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Hologic Recent Developments and Future Plans
2.11 Cepheid
2.11.1 Cepheid Details
2.11.2 Cepheid Major Business
2.11.3 Cepheid Sexually Transmitted Diseases Diagnostics Product and Solutions
2.11.4 Cepheid Sexually Transmitted Diseases Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Cepheid Recent Developments and Future Plans
2.12 BioMeriuex
2.12.1 BioMeriuex Details
2.12.2 BioMeriuex Major Business
2.12.3 BioMeriuex Sexually Transmitted Diseases Diagnostics Product and Solutions
2.12.4 BioMeriuex Sexually Transmitted Diseases Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 BioMeriuex Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Sexually Transmitted Diseases Diagnostics Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Sexually Transmitted Diseases Diagnostics by Company Revenue
3.2.2 Top 3 Sexually Transmitted Diseases Diagnostics Players Market Share in 2025
3.2.3 Top 6 Sexually Transmitted Diseases Diagnostics Players Market Share in 2025
3.3 Sexually Transmitted Diseases Diagnostics Market: Overall Company Footprint Analysis
3.3.1 Sexually Transmitted Diseases Diagnostics Market: Region Footprint
3.3.2 Sexually Transmitted Diseases Diagnostics Market: Company Product Type Footprint
3.3.3 Sexually Transmitted Diseases Diagnostics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Sexually Transmitted Diseases Diagnostics Consumption Value and Market Share by Type (2021-2026)
4.2 Global Sexually Transmitted Diseases Diagnostics Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Sexually Transmitted Diseases Diagnostics Consumption Value Market Share by Application (2021-2026)
5.2 Global Sexually Transmitted Diseases Diagnostics Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Sexually Transmitted Diseases Diagnostics Consumption Value by Type (2021-2032)
6.2 North America Sexually Transmitted Diseases Diagnostics Market Size by Application (2021-2032)
6.3 North America Sexually Transmitted Diseases Diagnostics Market Size by Country
6.3.1 North America Sexually Transmitted Diseases Diagnostics Consumption Value by Country (2021-2032)
6.3.2 United States Sexually Transmitted Diseases Diagnostics Market Size and Forecast (2021-2032)
6.3.3 Canada Sexually Transmitted Diseases Diagnostics Market Size and Forecast (2021-2032)
6.3.4 Mexico Sexually Transmitted Diseases Diagnostics Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Sexually Transmitted Diseases Diagnostics Consumption Value by Type (2021-2032)
7.2 Europe Sexually Transmitted Diseases Diagnostics Consumption Value by Application (2021-2032)
7.3 Europe Sexually Transmitted Diseases Diagnostics Market Size by Country
7.3.1 Europe Sexually Transmitted Diseases Diagnostics Consumption Value by Country (2021-2032)
7.3.2 Germany Sexually Transmitted Diseases Diagnostics Market Size and Forecast (2021-2032)
7.3.3 France Sexually Transmitted Diseases Diagnostics Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Sexually Transmitted Diseases Diagnostics Market Size and Forecast (2021-2032)
7.3.5 Russia Sexually Transmitted Diseases Diagnostics Market Size and Forecast (2021-2032)
7.3.6 Italy Sexually Transmitted Diseases Diagnostics Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Sexually Transmitted Diseases Diagnostics Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Sexually Transmitted Diseases Diagnostics Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Sexually Transmitted Diseases Diagnostics Market Size by Region
8.3.1 Asia-Pacific Sexually Transmitted Diseases Diagnostics Consumption Value by Region (2021-2032)
8.3.2 China Sexually Transmitted Diseases Diagnostics Market Size and Forecast (2021-2032)
8.3.3 Japan Sexually Transmitted Diseases Diagnostics Market Size and Forecast (2021-2032)
8.3.4 South Korea Sexually Transmitted Diseases Diagnostics Market Size and Forecast (2021-2032)
8.3.5 India Sexually Transmitted Diseases Diagnostics Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Sexually Transmitted Diseases Diagnostics Market Size and Forecast (2021-2032)
8.3.7 Australia Sexually Transmitted Diseases Diagnostics Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Sexually Transmitted Diseases Diagnostics Consumption Value by Type (2021-2032)
9.2 South America Sexually Transmitted Diseases Diagnostics Consumption Value by Application (2021-2032)
9.3 South America Sexually Transmitted Diseases Diagnostics Market Size by Country
9.3.1 South America Sexually Transmitted Diseases Diagnostics Consumption Value by Country (2021-2032)
9.3.2 Brazil Sexually Transmitted Diseases Diagnostics Market Size and Forecast (2021-2032)
9.3.3 Argentina Sexually Transmitted Diseases Diagnostics Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Sexually Transmitted Diseases Diagnostics Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Sexually Transmitted Diseases Diagnostics Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Sexually Transmitted Diseases Diagnostics Market Size by Country
10.3.1 Middle East & Africa Sexually Transmitted Diseases Diagnostics Consumption Value by Country (2021-2032)
10.3.2 Turkey Sexually Transmitted Diseases Diagnostics Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Sexually Transmitted Diseases Diagnostics Market Size and Forecast (2021-2032)
10.3.4 UAE Sexually Transmitted Diseases Diagnostics Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Sexually Transmitted Diseases Diagnostics Market Drivers
11.2 Sexually Transmitted Diseases Diagnostics Market Restraints
11.3 Sexually Transmitted Diseases Diagnostics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Sexually Transmitted Diseases Diagnostics Industry Chain
12.2 Sexually Transmitted Diseases Diagnostics Upstream Analysis
12.3 Sexually Transmitted Diseases Diagnostics Midstream Analysis
12.4 Sexually Transmitted Diseases Diagnostics Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Sexually Transmitted Diseases Diagnostics Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Sexually Transmitted Diseases Diagnostics Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. Global Sexually Transmitted Diseases Diagnostics Consumption Value by Region (2021-2026) & (USD Million)
Table 4. Global Sexually Transmitted Diseases Diagnostics Consumption Value by Region (2027-2032) & (USD Million)
Table 5. Abbott Company Information, Head Office, and Major Competitors
Table 6. Abbott Major Business
Table 7. Abbott Sexually Transmitted Diseases Diagnostics Product and Solutions
Table 8. Abbott Sexually Transmitted Diseases Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. Abbott Recent Developments and Future Plans
Table 10. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 11. Thermo Fisher Scientific Major Business
Table 12. Thermo Fisher Scientific Sexually Transmitted Diseases Diagnostics Product and Solutions
Table 13. Thermo Fisher Scientific Sexually Transmitted Diseases Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. Thermo Fisher Scientific Recent Developments and Future Plans
Table 15. CERTEST BIOTEC Company Information, Head Office, and Major Competitors
Table 16. CERTEST BIOTEC Major Business
Table 17. CERTEST BIOTEC Sexually Transmitted Diseases Diagnostics Product and Solutions
Table 18. CERTEST BIOTEC Sexually Transmitted Diseases Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. OPERON Company Information, Head Office, and Major Competitors
Table 20. OPERON Major Business
Table 21. OPERON Sexually Transmitted Diseases Diagnostics Product and Solutions
Table 22. OPERON Sexually Transmitted Diseases Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 23. OPERON Recent Developments and Future Plans
Table 24. Roche Company Information, Head Office, and Major Competitors
Table 25. Roche Major Business
Table 26. Roche Sexually Transmitted Diseases Diagnostics Product and Solutions
Table 27. Roche Sexually Transmitted Diseases Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 28. Roche Recent Developments and Future Plans
Table 29. Bio-Rad laboratories Company Information, Head Office, and Major Competitors
Table 30. Bio-Rad laboratories Major Business
Table 31. Bio-Rad laboratories Sexually Transmitted Diseases Diagnostics Product and Solutions
Table 32. Bio-Rad laboratories Sexually Transmitted Diseases Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 33. Bio-Rad laboratories Recent Developments and Future Plans
Table 34. Qaigen Company Information, Head Office, and Major Competitors
Table 35. Qaigen Major Business
Table 36. Qaigen Sexually Transmitted Diseases Diagnostics Product and Solutions
Table 37. Qaigen Sexually Transmitted Diseases Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 38. Qaigen Recent Developments and Future Plans
Table 39. Diasorin SPA Company Information, Head Office, and Major Competitors
Table 40. Diasorin SPA Major Business
Table 41. Diasorin SPA Sexually Transmitted Diseases Diagnostics Product and Solutions
Table 42. Diasorin SPA Sexually Transmitted Diseases Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 43. Diasorin SPA Recent Developments and Future Plans
Table 44. MedMira Company Information, Head Office, and Major Competitors
Table 45. MedMira Major Business
Table 46. MedMira Sexually Transmitted Diseases Diagnostics Product and Solutions
Table 47. MedMira Sexually Transmitted Diseases Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 48. MedMira Recent Developments and Future Plans
Table 49. Hologic Company Information, Head Office, and Major Competitors
Table 50. Hologic Major Business
Table 51. Hologic Sexually Transmitted Diseases Diagnostics Product and Solutions
Table 52. Hologic Sexually Transmitted Diseases Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 53. Hologic Recent Developments and Future Plans
Table 54. Cepheid Company Information, Head Office, and Major Competitors
Table 55. Cepheid Major Business
Table 56. Cepheid Sexually Transmitted Diseases Diagnostics Product and Solutions
Table 57. Cepheid Sexually Transmitted Diseases Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 58. Cepheid Recent Developments and Future Plans
Table 59. BioMeriuex Company Information, Head Office, and Major Competitors
Table 60. BioMeriuex Major Business
Table 61. BioMeriuex Sexually Transmitted Diseases Diagnostics Product and Solutions
Table 62. BioMeriuex Sexually Transmitted Diseases Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 63. BioMeriuex Recent Developments and Future Plans
Table 64. Global Sexually Transmitted Diseases Diagnostics Revenue (USD Million) by Players (2021-2026)
Table 65. Global Sexually Transmitted Diseases Diagnostics Revenue Share by Players (2021-2026)
Table 66. Breakdown of Sexually Transmitted Diseases Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 67. Market Position of Players in Sexually Transmitted Diseases Diagnostics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 68. Head Office of Key Sexually Transmitted Diseases Diagnostics Players
Table 69. Sexually Transmitted Diseases Diagnostics Market: Company Product Type Footprint
Table 70. Sexually Transmitted Diseases Diagnostics Market: Company Product Application Footprint
Table 71. Sexually Transmitted Diseases Diagnostics New Market Entrants and Barriers to Market Entry
Table 72. Sexually Transmitted Diseases Diagnostics Mergers, Acquisition, Agreements, and Collaborations
Table 73. Global Sexually Transmitted Diseases Diagnostics Consumption Value (USD Million) by Type (2021-2026)
Table 74. Global Sexually Transmitted Diseases Diagnostics Consumption Value Share by Type (2021-2026)
Table 75. Global Sexually Transmitted Diseases Diagnostics Consumption Value Forecast by Type (2027-2032)
Table 76. Global Sexually Transmitted Diseases Diagnostics Consumption Value by Application (2021-2026)
Table 77. Global Sexually Transmitted Diseases Diagnostics Consumption Value Forecast by Application (2027-2032)
Table 78. North America Sexually Transmitted Diseases Diagnostics Consumption Value by Type (2021-2026) & (USD Million)
Table 79. North America Sexually Transmitted Diseases Diagnostics Consumption Value by Type (2027-2032) & (USD Million)
Table 80. North America Sexually Transmitted Diseases Diagnostics Consumption Value by Application (2021-2026) & (USD Million)
Table 81. North America Sexually Transmitted Diseases Diagnostics Consumption Value by Application (2027-2032) & (USD Million)
Table 82. North America Sexually Transmitted Diseases Diagnostics Consumption Value by Country (2021-2026) & (USD Million)
Table 83. North America Sexually Transmitted Diseases Diagnostics Consumption Value by Country (2027-2032) & (USD Million)
Table 84. Europe Sexually Transmitted Diseases Diagnostics Consumption Value by Type (2021-2026) & (USD Million)
Table 85. Europe Sexually Transmitted Diseases Diagnostics Consumption Value by Type (2027-2032) & (USD Million)
Table 86. Europe Sexually Transmitted Diseases Diagnostics Consumption Value by Application (2021-2026) & (USD Million)
Table 87. Europe Sexually Transmitted Diseases Diagnostics Consumption Value by Application (2027-2032) & (USD Million)
Table 88. Europe Sexually Transmitted Diseases Diagnostics Consumption Value by Country (2021-2026) & (USD Million)
Table 89. Europe Sexually Transmitted Diseases Diagnostics Consumption Value by Country (2027-2032) & (USD Million)
Table 90. Asia-Pacific Sexually Transmitted Diseases Diagnostics Consumption Value by Type (2021-2026) & (USD Million)
Table 91. Asia-Pacific Sexually Transmitted Diseases Diagnostics Consumption Value by Type (2027-2032) & (USD Million)
Table 92. Asia-Pacific Sexually Transmitted Diseases Diagnostics Consumption Value by Application (2021-2026) & (USD Million)
Table 93. Asia-Pacific Sexually Transmitted Diseases Diagnostics Consumption Value by Application (2027-2032) & (USD Million)
Table 94. Asia-Pacific Sexually Transmitted Diseases Diagnostics Consumption Value by Region (2021-2026) & (USD Million)
Table 95. Asia-Pacific Sexually Transmitted Diseases Diagnostics Consumption Value by Region (2027-2032) & (USD Million)
Table 96. South America Sexually Transmitted Diseases Diagnostics Consumption Value by Type (2021-2026) & (USD Million)
Table 97. South America Sexually Transmitted Diseases Diagnostics Consumption Value by Type (2027-2032) & (USD Million)
Table 98. South America Sexually Transmitted Diseases Diagnostics Consumption Value by Application (2021-2026) & (USD Million)
Table 99. South America Sexually Transmitted Diseases Diagnostics Consumption Value by Application (2027-2032) & (USD Million)
Table 100. South America Sexually Transmitted Diseases Diagnostics Consumption Value by Country (2021-2026) & (USD Million)
Table 101. South America Sexually Transmitted Diseases Diagnostics Consumption Value by Country (2027-2032) & (USD Million)
Table 102. Middle East & Africa Sexually Transmitted Diseases Diagnostics Consumption Value by Type (2021-2026) & (USD Million)
Table 103. Middle East & Africa Sexually Transmitted Diseases Diagnostics Consumption Value by Type (2027-2032) & (USD Million)
Table 104. Middle East & Africa Sexually Transmitted Diseases Diagnostics Consumption Value by Application (2021-2026) & (USD Million)
Table 105. Middle East & Africa Sexually Transmitted Diseases Diagnostics Consumption Value by Application (2027-2032) & (USD Million)
Table 106. Middle East & Africa Sexually Transmitted Diseases Diagnostics Consumption Value by Country (2021-2026) & (USD Million)
Table 107. Middle East & Africa Sexually Transmitted Diseases Diagnostics Consumption Value by Country (2027-2032) & (USD Million)
Table 108. Global Key Players of Sexually Transmitted Diseases Diagnostics Upstream (Raw Materials)
Table 109. Global Sexually Transmitted Diseases Diagnostics Typical Customers
Table 1. Global Sexually Transmitted Diseases Diagnostics Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Sexually Transmitted Diseases Diagnostics Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. Global Sexually Transmitted Diseases Diagnostics Consumption Value by Region (2021-2026) & (USD Million)
Table 4. Global Sexually Transmitted Diseases Diagnostics Consumption Value by Region (2027-2032) & (USD Million)
Table 5. Abbott Company Information, Head Office, and Major Competitors
Table 6. Abbott Major Business
Table 7. Abbott Sexually Transmitted Diseases Diagnostics Product and Solutions
Table 8. Abbott Sexually Transmitted Diseases Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. Abbott Recent Developments and Future Plans
Table 10. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 11. Thermo Fisher Scientific Major Business
Table 12. Thermo Fisher Scientific Sexually Transmitted Diseases Diagnostics Product and Solutions
Table 13. Thermo Fisher Scientific Sexually Transmitted Diseases Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. Thermo Fisher Scientific Recent Developments and Future Plans
Table 15. CERTEST BIOTEC Company Information, Head Office, and Major Competitors
Table 16. CERTEST BIOTEC Major Business
Table 17. CERTEST BIOTEC Sexually Transmitted Diseases Diagnostics Product and Solutions
Table 18. CERTEST BIOTEC Sexually Transmitted Diseases Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. OPERON Company Information, Head Office, and Major Competitors
Table 20. OPERON Major Business
Table 21. OPERON Sexually Transmitted Diseases Diagnostics Product and Solutions
Table 22. OPERON Sexually Transmitted Diseases Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 23. OPERON Recent Developments and Future Plans
Table 24. Roche Company Information, Head Office, and Major Competitors
Table 25. Roche Major Business
Table 26. Roche Sexually Transmitted Diseases Diagnostics Product and Solutions
Table 27. Roche Sexually Transmitted Diseases Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 28. Roche Recent Developments and Future Plans
Table 29. Bio-Rad laboratories Company Information, Head Office, and Major Competitors
Table 30. Bio-Rad laboratories Major Business
Table 31. Bio-Rad laboratories Sexually Transmitted Diseases Diagnostics Product and Solutions
Table 32. Bio-Rad laboratories Sexually Transmitted Diseases Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 33. Bio-Rad laboratories Recent Developments and Future Plans
Table 34. Qaigen Company Information, Head Office, and Major Competitors
Table 35. Qaigen Major Business
Table 36. Qaigen Sexually Transmitted Diseases Diagnostics Product and Solutions
Table 37. Qaigen Sexually Transmitted Diseases Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 38. Qaigen Recent Developments and Future Plans
Table 39. Diasorin SPA Company Information, Head Office, and Major Competitors
Table 40. Diasorin SPA Major Business
Table 41. Diasorin SPA Sexually Transmitted Diseases Diagnostics Product and Solutions
Table 42. Diasorin SPA Sexually Transmitted Diseases Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 43. Diasorin SPA Recent Developments and Future Plans
Table 44. MedMira Company Information, Head Office, and Major Competitors
Table 45. MedMira Major Business
Table 46. MedMira Sexually Transmitted Diseases Diagnostics Product and Solutions
Table 47. MedMira Sexually Transmitted Diseases Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 48. MedMira Recent Developments and Future Plans
Table 49. Hologic Company Information, Head Office, and Major Competitors
Table 50. Hologic Major Business
Table 51. Hologic Sexually Transmitted Diseases Diagnostics Product and Solutions
Table 52. Hologic Sexually Transmitted Diseases Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 53. Hologic Recent Developments and Future Plans
Table 54. Cepheid Company Information, Head Office, and Major Competitors
Table 55. Cepheid Major Business
Table 56. Cepheid Sexually Transmitted Diseases Diagnostics Product and Solutions
Table 57. Cepheid Sexually Transmitted Diseases Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 58. Cepheid Recent Developments and Future Plans
Table 59. BioMeriuex Company Information, Head Office, and Major Competitors
Table 60. BioMeriuex Major Business
Table 61. BioMeriuex Sexually Transmitted Diseases Diagnostics Product and Solutions
Table 62. BioMeriuex Sexually Transmitted Diseases Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 63. BioMeriuex Recent Developments and Future Plans
Table 64. Global Sexually Transmitted Diseases Diagnostics Revenue (USD Million) by Players (2021-2026)
Table 65. Global Sexually Transmitted Diseases Diagnostics Revenue Share by Players (2021-2026)
Table 66. Breakdown of Sexually Transmitted Diseases Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 67. Market Position of Players in Sexually Transmitted Diseases Diagnostics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 68. Head Office of Key Sexually Transmitted Diseases Diagnostics Players
Table 69. Sexually Transmitted Diseases Diagnostics Market: Company Product Type Footprint
Table 70. Sexually Transmitted Diseases Diagnostics Market: Company Product Application Footprint
Table 71. Sexually Transmitted Diseases Diagnostics New Market Entrants and Barriers to Market Entry
Table 72. Sexually Transmitted Diseases Diagnostics Mergers, Acquisition, Agreements, and Collaborations
Table 73. Global Sexually Transmitted Diseases Diagnostics Consumption Value (USD Million) by Type (2021-2026)
Table 74. Global Sexually Transmitted Diseases Diagnostics Consumption Value Share by Type (2021-2026)
Table 75. Global Sexually Transmitted Diseases Diagnostics Consumption Value Forecast by Type (2027-2032)
Table 76. Global Sexually Transmitted Diseases Diagnostics Consumption Value by Application (2021-2026)
Table 77. Global Sexually Transmitted Diseases Diagnostics Consumption Value Forecast by Application (2027-2032)
Table 78. North America Sexually Transmitted Diseases Diagnostics Consumption Value by Type (2021-2026) & (USD Million)
Table 79. North America Sexually Transmitted Diseases Diagnostics Consumption Value by Type (2027-2032) & (USD Million)
Table 80. North America Sexually Transmitted Diseases Diagnostics Consumption Value by Application (2021-2026) & (USD Million)
Table 81. North America Sexually Transmitted Diseases Diagnostics Consumption Value by Application (2027-2032) & (USD Million)
Table 82. North America Sexually Transmitted Diseases Diagnostics Consumption Value by Country (2021-2026) & (USD Million)
Table 83. North America Sexually Transmitted Diseases Diagnostics Consumption Value by Country (2027-2032) & (USD Million)
Table 84. Europe Sexually Transmitted Diseases Diagnostics Consumption Value by Type (2021-2026) & (USD Million)
Table 85. Europe Sexually Transmitted Diseases Diagnostics Consumption Value by Type (2027-2032) & (USD Million)
Table 86. Europe Sexually Transmitted Diseases Diagnostics Consumption Value by Application (2021-2026) & (USD Million)
Table 87. Europe Sexually Transmitted Diseases Diagnostics Consumption Value by Application (2027-2032) & (USD Million)
Table 88. Europe Sexually Transmitted Diseases Diagnostics Consumption Value by Country (2021-2026) & (USD Million)
Table 89. Europe Sexually Transmitted Diseases Diagnostics Consumption Value by Country (2027-2032) & (USD Million)
Table 90. Asia-Pacific Sexually Transmitted Diseases Diagnostics Consumption Value by Type (2021-2026) & (USD Million)
Table 91. Asia-Pacific Sexually Transmitted Diseases Diagnostics Consumption Value by Type (2027-2032) & (USD Million)
Table 92. Asia-Pacific Sexually Transmitted Diseases Diagnostics Consumption Value by Application (2021-2026) & (USD Million)
Table 93. Asia-Pacific Sexually Transmitted Diseases Diagnostics Consumption Value by Application (2027-2032) & (USD Million)
Table 94. Asia-Pacific Sexually Transmitted Diseases Diagnostics Consumption Value by Region (2021-2026) & (USD Million)
Table 95. Asia-Pacific Sexually Transmitted Diseases Diagnostics Consumption Value by Region (2027-2032) & (USD Million)
Table 96. South America Sexually Transmitted Diseases Diagnostics Consumption Value by Type (2021-2026) & (USD Million)
Table 97. South America Sexually Transmitted Diseases Diagnostics Consumption Value by Type (2027-2032) & (USD Million)
Table 98. South America Sexually Transmitted Diseases Diagnostics Consumption Value by Application (2021-2026) & (USD Million)
Table 99. South America Sexually Transmitted Diseases Diagnostics Consumption Value by Application (2027-2032) & (USD Million)
Table 100. South America Sexually Transmitted Diseases Diagnostics Consumption Value by Country (2021-2026) & (USD Million)
Table 101. South America Sexually Transmitted Diseases Diagnostics Consumption Value by Country (2027-2032) & (USD Million)
Table 102. Middle East & Africa Sexually Transmitted Diseases Diagnostics Consumption Value by Type (2021-2026) & (USD Million)
Table 103. Middle East & Africa Sexually Transmitted Diseases Diagnostics Consumption Value by Type (2027-2032) & (USD Million)
Table 104. Middle East & Africa Sexually Transmitted Diseases Diagnostics Consumption Value by Application (2021-2026) & (USD Million)
Table 105. Middle East & Africa Sexually Transmitted Diseases Diagnostics Consumption Value by Application (2027-2032) & (USD Million)
Table 106. Middle East & Africa Sexually Transmitted Diseases Diagnostics Consumption Value by Country (2021-2026) & (USD Million)
Table 107. Middle East & Africa Sexually Transmitted Diseases Diagnostics Consumption Value by Country (2027-2032) & (USD Million)
Table 108. Global Key Players of Sexually Transmitted Diseases Diagnostics Upstream (Raw Materials)
Table 109. Global Sexually Transmitted Diseases Diagnostics Typical Customers
LIST OF FIGURES
Figure 1. Sexually Transmitted Diseases Diagnostics Picture
Figure 2. Global Sexually Transmitted Diseases Diagnostics Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Sexually Transmitted Diseases Diagnostics Consumption Value Market Share by Type in 2025
Figure 4. Cultural and Isolated Organisms
Figure 5. Molecular Test
Figure 6. Immunology Assay
Figure 7. Other
Figure 8. Global Sexually Transmitted Diseases Diagnostics Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 9. Sexually Transmitted Diseases Diagnostics Consumption Value Market Share by Application in 2025
Figure 10. Gonorrhea Picture
Figure 11. Syphilis Picture
Figure 12. Chlamydia Picture
Figure 13. Herpes Simplex Virus Picture
Figure 14. Human Papillomavirus Picture
Figure 15. Others Picture
Figure 16. Global Sexually Transmitted Diseases Diagnostics Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 17. Global Sexually Transmitted Diseases Diagnostics Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 18. Global Market Sexually Transmitted Diseases Diagnostics Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 19. Global Sexually Transmitted Diseases Diagnostics Consumption Value Market Share by Region (2021-2032)
Figure 20. Global Sexually Transmitted Diseases Diagnostics Consumption Value Market Share by Region in 2025
Figure 21. North America Sexually Transmitted Diseases Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 22. Europe Sexually Transmitted Diseases Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 23. Asia-Pacific Sexually Transmitted Diseases Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 24. South America Sexually Transmitted Diseases Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 25. Middle East & Africa Sexually Transmitted Diseases Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 26. Company Three Recent Developments and Future Plans
Figure 27. Global Sexually Transmitted Diseases Diagnostics Revenue Share by Players in 2025
Figure 28. Sexually Transmitted Diseases Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 29. Market Share of Sexually Transmitted Diseases Diagnostics by Player Revenue in 2025
Figure 30. Top 3 Sexually Transmitted Diseases Diagnostics Players Market Share in 2025
Figure 31. Top 6 Sexually Transmitted Diseases Diagnostics Players Market Share in 2025
Figure 32. Global Sexually Transmitted Diseases Diagnostics Consumption Value Share by Type (2021-2026)
Figure 33. Global Sexually Transmitted Diseases Diagnostics Market Share Forecast by Type (2027-2032)
Figure 34. Global Sexually Transmitted Diseases Diagnostics Consumption Value Share by Application (2021-2026)
Figure 35. Global Sexually Transmitted Diseases Diagnostics Market Share Forecast by Application (2027-2032)
Figure 36. North America Sexually Transmitted Diseases Diagnostics Consumption Value Market Share by Type (2021-2032)
Figure 37. North America Sexually Transmitted Diseases Diagnostics Consumption Value Market Share by Application (2021-2032)
Figure 38. North America Sexually Transmitted Diseases Diagnostics Consumption Value Market Share by Country (2021-2032)
Figure 39. United States Sexually Transmitted Diseases Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 40. Canada Sexually Transmitted Diseases Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 41. Mexico Sexually Transmitted Diseases Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 42. Europe Sexually Transmitted Diseases Diagnostics Consumption Value Market Share by Type (2021-2032)
Figure 43. Europe Sexually Transmitted Diseases Diagnostics Consumption Value Market Share by Application (2021-2032)
Figure 44. Europe Sexually Transmitted Diseases Diagnostics Consumption Value Market Share by Country (2021-2032)
Figure 45. Germany Sexually Transmitted Diseases Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 46. France Sexually Transmitted Diseases Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 47. United Kingdom Sexually Transmitted Diseases Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 48. Russia Sexually Transmitted Diseases Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 49. Italy Sexually Transmitted Diseases Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 50. Asia-Pacific Sexually Transmitted Diseases Diagnostics Consumption Value Market Share by Type (2021-2032)
Figure 51. Asia-Pacific Sexually Transmitted Diseases Diagnostics Consumption Value Market Share by Application (2021-2032)
Figure 52. Asia-Pacific Sexually Transmitted Diseases Diagnostics Consumption Value Market Share by Region (2021-2032)
Figure 53. China Sexually Transmitted Diseases Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 54. Japan Sexually Transmitted Diseases Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 55. South Korea Sexually Transmitted Diseases Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 56. India Sexually Transmitted Diseases Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 57. Southeast Asia Sexually Transmitted Diseases Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 58. Australia Sexually Transmitted Diseases Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 59. South America Sexually Transmitted Diseases Diagnostics Consumption Value Market Share by Type (2021-2032)
Figure 60. South America Sexually Transmitted Diseases Diagnostics Consumption Value Market Share by Application (2021-2032)
Figure 61. South America Sexually Transmitted Diseases Diagnostics Consumption Value Market Share by Country (2021-2032)
Figure 62. Brazil Sexually Transmitted Diseases Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 63. Argentina Sexually Transmitted Diseases Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 64. Middle East & Africa Sexually Transmitted Diseases Diagnostics Consumption Value Market Share by Type (2021-2032)
Figure 65. Middle East & Africa Sexually Transmitted Diseases Diagnostics Consumption Value Market Share by Application (2021-2032)
Figure 66. Middle East & Africa Sexually Transmitted Diseases Diagnostics Consumption Value Market Share by Country (2021-2032)
Figure 67. Turkey Sexually Transmitted Diseases Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 68. Saudi Arabia Sexually Transmitted Diseases Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 69. UAE Sexually Transmitted Diseases Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 70. Sexually Transmitted Diseases Diagnostics Market Drivers
Figure 71. Sexually Transmitted Diseases Diagnostics Market Restraints
Figure 72. Sexually Transmitted Diseases Diagnostics Market Trends
Figure 73. Porters Five Forces Analysis
Figure 74. Sexually Transmitted Diseases Diagnostics Industrial Chain
Figure 75. Methodology
Figure 76. Research Process and Data Source
Figure 1. Sexually Transmitted Diseases Diagnostics Picture
Figure 2. Global Sexually Transmitted Diseases Diagnostics Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Sexually Transmitted Diseases Diagnostics Consumption Value Market Share by Type in 2025
Figure 4. Cultural and Isolated Organisms
Figure 5. Molecular Test
Figure 6. Immunology Assay
Figure 7. Other
Figure 8. Global Sexually Transmitted Diseases Diagnostics Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 9. Sexually Transmitted Diseases Diagnostics Consumption Value Market Share by Application in 2025
Figure 10. Gonorrhea Picture
Figure 11. Syphilis Picture
Figure 12. Chlamydia Picture
Figure 13. Herpes Simplex Virus Picture
Figure 14. Human Papillomavirus Picture
Figure 15. Others Picture
Figure 16. Global Sexually Transmitted Diseases Diagnostics Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 17. Global Sexually Transmitted Diseases Diagnostics Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 18. Global Market Sexually Transmitted Diseases Diagnostics Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 19. Global Sexually Transmitted Diseases Diagnostics Consumption Value Market Share by Region (2021-2032)
Figure 20. Global Sexually Transmitted Diseases Diagnostics Consumption Value Market Share by Region in 2025
Figure 21. North America Sexually Transmitted Diseases Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 22. Europe Sexually Transmitted Diseases Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 23. Asia-Pacific Sexually Transmitted Diseases Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 24. South America Sexually Transmitted Diseases Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 25. Middle East & Africa Sexually Transmitted Diseases Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 26. Company Three Recent Developments and Future Plans
Figure 27. Global Sexually Transmitted Diseases Diagnostics Revenue Share by Players in 2025
Figure 28. Sexually Transmitted Diseases Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 29. Market Share of Sexually Transmitted Diseases Diagnostics by Player Revenue in 2025
Figure 30. Top 3 Sexually Transmitted Diseases Diagnostics Players Market Share in 2025
Figure 31. Top 6 Sexually Transmitted Diseases Diagnostics Players Market Share in 2025
Figure 32. Global Sexually Transmitted Diseases Diagnostics Consumption Value Share by Type (2021-2026)
Figure 33. Global Sexually Transmitted Diseases Diagnostics Market Share Forecast by Type (2027-2032)
Figure 34. Global Sexually Transmitted Diseases Diagnostics Consumption Value Share by Application (2021-2026)
Figure 35. Global Sexually Transmitted Diseases Diagnostics Market Share Forecast by Application (2027-2032)
Figure 36. North America Sexually Transmitted Diseases Diagnostics Consumption Value Market Share by Type (2021-2032)
Figure 37. North America Sexually Transmitted Diseases Diagnostics Consumption Value Market Share by Application (2021-2032)
Figure 38. North America Sexually Transmitted Diseases Diagnostics Consumption Value Market Share by Country (2021-2032)
Figure 39. United States Sexually Transmitted Diseases Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 40. Canada Sexually Transmitted Diseases Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 41. Mexico Sexually Transmitted Diseases Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 42. Europe Sexually Transmitted Diseases Diagnostics Consumption Value Market Share by Type (2021-2032)
Figure 43. Europe Sexually Transmitted Diseases Diagnostics Consumption Value Market Share by Application (2021-2032)
Figure 44. Europe Sexually Transmitted Diseases Diagnostics Consumption Value Market Share by Country (2021-2032)
Figure 45. Germany Sexually Transmitted Diseases Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 46. France Sexually Transmitted Diseases Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 47. United Kingdom Sexually Transmitted Diseases Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 48. Russia Sexually Transmitted Diseases Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 49. Italy Sexually Transmitted Diseases Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 50. Asia-Pacific Sexually Transmitted Diseases Diagnostics Consumption Value Market Share by Type (2021-2032)
Figure 51. Asia-Pacific Sexually Transmitted Diseases Diagnostics Consumption Value Market Share by Application (2021-2032)
Figure 52. Asia-Pacific Sexually Transmitted Diseases Diagnostics Consumption Value Market Share by Region (2021-2032)
Figure 53. China Sexually Transmitted Diseases Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 54. Japan Sexually Transmitted Diseases Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 55. South Korea Sexually Transmitted Diseases Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 56. India Sexually Transmitted Diseases Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 57. Southeast Asia Sexually Transmitted Diseases Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 58. Australia Sexually Transmitted Diseases Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 59. South America Sexually Transmitted Diseases Diagnostics Consumption Value Market Share by Type (2021-2032)
Figure 60. South America Sexually Transmitted Diseases Diagnostics Consumption Value Market Share by Application (2021-2032)
Figure 61. South America Sexually Transmitted Diseases Diagnostics Consumption Value Market Share by Country (2021-2032)
Figure 62. Brazil Sexually Transmitted Diseases Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 63. Argentina Sexually Transmitted Diseases Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 64. Middle East & Africa Sexually Transmitted Diseases Diagnostics Consumption Value Market Share by Type (2021-2032)
Figure 65. Middle East & Africa Sexually Transmitted Diseases Diagnostics Consumption Value Market Share by Application (2021-2032)
Figure 66. Middle East & Africa Sexually Transmitted Diseases Diagnostics Consumption Value Market Share by Country (2021-2032)
Figure 67. Turkey Sexually Transmitted Diseases Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 68. Saudi Arabia Sexually Transmitted Diseases Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 69. UAE Sexually Transmitted Diseases Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 70. Sexually Transmitted Diseases Diagnostics Market Drivers
Figure 71. Sexually Transmitted Diseases Diagnostics Market Restraints
Figure 72. Sexually Transmitted Diseases Diagnostics Market Trends
Figure 73. Porters Five Forces Analysis
Figure 74. Sexually Transmitted Diseases Diagnostics Industrial Chain
Figure 75. Methodology
Figure 76. Research Process and Data Source
